Pfizer CEO, Albert Bourla, announced yesterday that an antiviral pill to treat Covid-19 may be available by the end of the year. The pill, taken orally at home, would be effective at the first sign of Covid-19 infection or exposure, and is expected to be effective against variants. Pfizer is testing two antivirals, one intravenous […]
Covid-19 and Lyme Disease
We have assembled useful articles to help guide you and your loved ones as we enter the “new normal”.
Please stay safe – we are all in this together!
An April 14, 2021 PLOS 1 study, Cynthia Otto et al., 2021, suggests that specially trained dogs can sniff out COVID-19 samples with 96% accuracy. The study, “Discrimination of SARS-CoV-2 infected patient samples by detection dogs: A proof of concept study,” comes out of the University of Pennsylvania School of Veterinary Medicine Working Dog Center. […]
According to a Dartmouth-Hitchcock press release, Dartmouth-Hitchcock Medical Center (DHMC) was one of 18 sites that conducted patient trials with lenzilumab and found this drug to be a safe, well-tolerated, and highly effective treatment against COVID-19.
In this study, researchers found that multiplex COVID-19 Immunoblot (IB) assays offer many advantages for evaluating antibody responses to multiple SARS-CoV-2 proteins in a single sample in COVID-19 patients.
A randomized research study sponsored by Washington University School of Medicine seeks participants age 30 and older, who have tested positive for COVID-19, and are currently experiencing mild symptoms.
Dr. John Aucott, Director of The Lyme Disease Research Center, Division of Rheumatology, Department of Medicine at Johns Hopkins University School of Medicine, et al. published the article, “Long-haul COVID: heed the lessons from other infection-triggered illnesses” in The Lancet.
A peer-reviewed report co-authored by Melissa C Fesler and Raphael B Stricker has been published in the International Journal of General Medicine which evaluates pre-exposure prophylaxis (PrEP) using medications approved for use in pregnant women to prevent gestational problems and severe illness in this high-risk population.
Update 2/27/21: The FDA has approved J&J’s Covid-19 vaccine for emergency use Feb. 24, 2021 – the Food & Drug Administration (FDA) has indicated Johnson & Johnson’s COVID-19 vaccine has met requirements for emergency use authorization (EUA). The report from staff will be used to brief the Vaccines & Related Biological Products Advisory Committee meeting, […]